2 Matching Annotations
  1. Jun 2021
  2. www.infectiousdiseaseadvisor.com www.infectiousdiseaseadvisor.com
    COVID-19 Vaccine Efficacy After First Dose: Pfizer, Moderna, AstraZeneca - Infectious Disease Advisor
    1
    1. zoe_ikeotuonye 27 Jun 2021

      COVID-19 Vaccine Efficacy After First Dose: Pfizer, Moderna, AstraZeneca. (2021, February 25). Infectious Disease Advisor. https://www.infectiousdiseaseadvisor.com/home/topics/covid19/pfizer-moderna-coronavirus-vaccine-first-dose-high-efficacy-bnt162b2-mrna1273-astrazeneca/

      is:webpage lang:en COVID-19 vaccine vaccination emerging diseases respiratory health health policy
    Visit annotations in context

    Tags

    Annotators

    URL

    infectiousdiseaseadvisor.com/home/topics/covid19/pfizer-moderna-coronavirus-vaccine-first-dose-high-efficacy-bnt162b2-mrna1273-astrazeneca/
  3. Aug 2020
  4. www.nber.org www.nber.org
    Financing Vaccines for Global Health Security
    1
    1. katietaylor_99 11 Aug 2020

      Vu, Jonathan T, Benjamin K Kaplan, Shomesh Chaudhuri, Monique K Mansoura, and Andrew W Lo. ‘Financing Vaccines for Global Health Security’. Working Paper. Working Paper Series. National Bureau of Economic Research, May 2020. https://doi.org/10.3386/w27212.

      is:report lang:en COVID-19 vaccines global health security pathogens Zika Ebola emerging infectious diseases EIDs cost risk public-sector private-sector financing deficit solutions partnerships subscription models
    Visit annotations in context

    Tags

    Annotators

    URL

    nber.org/papers/w27212